UiPath Announces 2025 AI25 Awards Winners

Annual awards program honors the most innovative AI and a gentic automation implementations of the UiPath Platform™

UiPath (NYSE: PATH), a global leader in agentic automation , today announced the winners of its UiPath AI25 Awards program . The annual program recognizes the 25 most innovative UiPath customers using the UiPath Platform ™ for Agentic Automation to expand the automation and AI potential of their organization. The 25 winning organizations will be honored at UiPath FUSION , UiPath's annual gathering of agentic automation experts and practitioners.

AI25 winners are leveraging AI and agentic automation—which combines the capabilities of AI agents , people, and robots—to deliver never-before-seen levels of productivity in their organizations, focusing not only on automating individual tasks, but on entire end-to-end processes. UiPath customers worldwide submitted applications detailing how they have used AI and agentic automation to redefine what's possible—not just in business, but in the ways we work and live.

The winners were selected by a panel of expert third-party judges based on the effective articulation of the business drivers, implementation, and results of their agentic and AI journey with UiPath.

The 2025 class of AI25 Award winners include:

  • AGS Health
  • Allegis Global Solutions
  • Buchanan
  • Coca-Cola İçecek
  • Continental Resources
  • CSL
  • Deluxe
  • Health Services Platform for a Leading Global Insurer
  • Fiserv
  • Internal Revenue Service
  • LC WAIKIKI
  • Lightera
  • Omega Healthcare
  • PromptCare
  • Schnellecke Logistics
  • Schulz & Partner Rechtsanwaltskanzlei
  • Suncoast Credit Union
  • SunExpress
  • Tetra Pak
  • The Clorox Company
  • TUI Group
  • United Wholesale Mortgage
  • VERTIV
  • Volkswagen Financial Services
  • WEX

In addition, several customers were selected as honorable mentions, including:

  • Cato Networks
  • Global advertising and marketing services network
  • Evergen
  • Regis Aged Care
  • A Southeast Asian global investment company
  • Winn Group

"This year's winners prove the transformative power of AI and agentic automation. They're solving critical business challenges and delivering real ROI," said Graham Sheldon, Chief Product Officer at UiPath and Executive Sponsor for the AI25 Awards. "We're proud to celebrate their success and to continue helping every customer capture the full value of AI and agentic automation."

About UiPath

UiPath (NYSE: PATH) is a global leader in agentic automation , empowering enterprises to harness the full potential of AI agents to autonomously execute and optimize complex business processes. The UiPath Platform™ uniquely combines controlled agency, developer flexibility, and seamless integration to help organizations scale agentic automation safely and confidently. Committed to security, governance, and interoperability, UiPath supports enterprises as they transition into a future where automation delivers on the full potential of AI to transform industries. For more information, visit www.uipath.com .

Media Contact
Christian Potts
UiPath
pr@uipath.com

Investor Relations Contact
Allise Furlani
UiPath
investor.relations@uipath.com

News Provided by Business Wire via QuoteMedia

PATH
The Conversation (0)
Numinus Wellness Provides Corporate Update

Numinus Wellness Provides Corporate Update

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update.Change of auditorsOn October 10,... Keep Reading...
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with acute myocarditis.Results provide clinical evidence that CardiolRx™ reduces inflammation-driven... Keep Reading...
Altech Batteries Ltd  Board Renewal and Strategic Focus

Altech Batteries Ltd Board Renewal and Strategic Focus

Perth, Australia (ABN Newswire) - Altech Batteries Limited (ASX:ATC,OTC:ALTHF) (FRA:A3Y) (OTCMKTS:ALTHF) advised that its newly constituted Board has commenced a comprehensive strategic reset to position the Company for successful commercialisation of its core battery technologies. The refreshed... Keep Reading...
Locksley Resources Limited  Drill Program Operations Commence at El Campo

Locksley Resources Limited Drill Program Operations Commence at El Campo

Perth, Australia (ABN Newswire) - Locksley Resources Limited (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) provided a significant operational update for its Mojave Project in California, confirming that the project has now transitioned into the drilling program phase. HIGHLIGHTS - Activities... Keep Reading...

Latest Press Releases

Related News